Search Results - Dalgleish, Angus

Refine Results
  1. 1
    Vaccines versus immunotherapy: Overview of approaches in deciding between options

    Vaccines versus immunotherapy: Overview of approaches in deciding between options by Dalgleish, Angus G

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12–13, 2017, Royal Society, London, UK

    The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12–13, 2017, Royal Society, London, UK by Dalgleish, Angus G

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    The Power of the Web in Cancer Drug Discovery and Clinical Trial Design: Research without a Laboratory?

    The Power of the Web in Cancer Drug Discovery and Clinical Trial Design: Research without a Laboratory? by Galustian, Christine, Dalgleish, Angus G.

    Published 2010
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines

    Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines by Cadogan, Martin, Dalgleish, Angus G

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    A heat-killed preparation of mycobacterium obuense can reduce metastatic burden in vivo

    A heat-killed preparation of mycobacterium obuense can reduce metastatic burden in vivo by Fowler, Daniel, Dalgleish, Angus, Liu, Wai

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    The failure of radical treatments to cure cancer: can less deliver more?

    The failure of radical treatments to cure cancer: can less deliver more? by Dalgleish, Angus G., Stern, Peter L.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients

    The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients by Dalgleish, Angus G., Liu, Wai M.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Developments in HIV-1 immunotherapy and therapeutic vaccination

    Developments in HIV-1 immunotherapy and therapeutic vaccination by Smith, Peter Lawrence, Tanner, Helen, Dalgleish, Angus

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity

    Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity by Dalgleish, Angus G., Mudan, Satvinder, Fusi, Alberto

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity

    Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity by Sørensen, Birger, Susrud, Andres, Dalgleish, Angus George

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors

    Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors by Cant, Rachel, Dalgleish, Angus G., Allen, Rachel L.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells

    In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells by Gravett, Andrew M., Dalgleish, Angus G., Copier, John

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy

    Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy by Smith, Peter Lawrence, Piadel, Katarzyna, Dalgleish, Angus George

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Long-term benefit from immune modulation and anti-inflammatory treatment in metastatic mesothelioma

    Long-term benefit from immune modulation and anti-inflammatory treatment in metastatic mesothelioma by Dalgleish, Angus G., McLean, Emma, Patel, Nirav, Rahman, Najib

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2

    Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2 by Piadel, Katarzyna, Haybatollahi, Amin, Dalgleish, Angus George, Smith, Peter Lawrence

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

    Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells by Ioannou, Nikolaos, Seddon, Alan M, Dalgleish, Angus, Mackintosh, David, Modjtahedi, Helmout

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer

    IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer by Bilyard, Hilary, Mines, Charlotte, Brunet, Laura Rosa, Dalgleish, Angus, Macintosh, Frances

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma

    Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma by Cananzi, Ferdinando CM, Mudan, Satvinder, Dunne, Mary, Belonwu, Nneka, Dalgleish, Angus G

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing

    Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing by Fowler, Daniel W, Copier, John, Dalgleish, Angus G, Bodman-Smith, Mark D

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner

    Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner by Fowler, Daniel W., Copier, John, Dalgleish, Angus G., Bodman-Smith, Mark D.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: